Eradication of Helicobacter pylori by a 1-week course of famotidine, amoxicillin and clarithromycin.

Objectives: The combination of a proton pump inhibitor (PPI) such as omeprazole with amoxicillin and clarithromycin constitutes one of the most effective treatments for the eradication of Helicobacter pylori. Nevertheless, the mechanisms of interaction between these drugs remain unclear. It has been...

Descripción completa

Detalles Bibliográficos
Publicado en:European Journal of Gastroenterology & Hepatology Vol. 10; no. 7; pp. 579 - 583
Autores principales: Gschwantler, Michael, Dragosics, Brigitte, Wurzer, Herbert, Brandstätter, Gerald, Weiss, Werner, Gschwantler, M, Dragosics, B, Wurzer, H, Brandstätter, G, Weiss, W
Formato: clinical trial research Journal Article
Publicado: Lippincott Williams & Wilkins Jul1998
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=110640786&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 110640786
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        0954691X
        8CE
      jtl: European Journal of Gastroenterology & Hepatology
      issn: 0954691X
      maglogo: N
    pubinfo:
      dt: Jul1998
      vid: 10
      iid: 7
      pid: 5086
      pub: Lippincott Williams & Wilkins
      place: Baltimore, Maryland
    artinfo:
      ui:
        110640786
        110640786
        NLM9855082
        110640786
        10.1097/00042737-199807000-00010
        NLM9855082
        110640786
      ppf: 579
      ppct: 4
      formats:
      tig:
        atl: Eradication of Helicobacter pylori by a 1-week course of famotidine, amoxicillin and clarithromycin.
      aug:
        au:
          Gschwantler, Michael
          Dragosics, Brigitte
          Wurzer, Herbert
          Brandstätter, Gerald
          Weiss, Werner
          Gschwantler, M
          Dragosics, B
          Wurzer, H
          Brandstätter, G
          Weiss, W
        affil: 4th Department of Internal Medicine, KA Rudolfstiftung, Vienna, Austria; bAmbulatory Care Centre South, Regional Public Medical Insurance Agency, Vienna, Austria; and the c2nd Medical Department, General Hospital, Graz, Austria
      sug:
        subj:
          Histamine H2 Antagonists Therapeutic Use
          Helicobacter Pylori
          Helicobacter Infections Drug Therapy
          Famotidine Therapeutic Use
          Penicillins Therapeutic Use
          Amoxicillin Therapeutic Use
          Antibiotics Therapeutic Use
          Adult
          Drug Therapy, Combination
          Treatment Outcomes
          Aged
          Peptic Ulcer Microbiology
          Male
          Middle Age
          Human
          Pilot Studies
          Prospective Studies
          Female
          Antibiotics, Macrolide
          Duodenal Ulcer Drug Therapy
          Peptic Ulcer Drug Therapy
          Duodenal Ulcer Microbiology
          Clinical Trials
          Validation Studies
          Comparative Studies
          Evaluation Research
          Multicenter Studies
          Adult: 19-44 years
          Aged: 65+ years
          Middle Aged: 45-64 years
          Male
          Female
      ab: Objectives: The combination of a proton pump inhibitor (PPI) such as omeprazole with amoxicillin and clarithromycin constitutes one of the most effective treatments for the eradication of Helicobacter pylori. Nevertheless, the mechanisms of interaction between these drugs remain unclear. It has been shown that minimal inhibitory concentration values of both antibiotics are considerably lower at neutral pH levels than in an acid environment. Further, omeprazole possesses bacteriostatic activity. To evaluate the significance of these mechanisms we replaced omeprazole with famotidine, a drug which only suppresses acid production, but has no intrinsic antimicrobial activity.Methods: We evaluated the efficacy of a 1-week course of famotidine 80 mg b.i.d., amoxicillin 1000 mg b.i.d. and clarithromycin 500 mg b.i.d. in a pilot study (20 patients), and then confirmed our results in a larger replication study (87 patients). A total of 107 patients with H. pylori-associated duodenal ulcer (n = 54), gastric ulcer (n = 14) or non-ulcer dyspepsia (n = 39) were included. Endoscopy was performed at baseline and 4-6 weeks after discontinuation of treatment. H. pylori status was assessed by the urease test and histology.Results: H. pylori was successfully eradicated in 94 of 104 patients who completed the study (90.4%; CI 95%, 83.0-95.3%). By intention-to-treat analysis, the eradication rate was 87.9% (CI 95%, 80.1-93.4%). Ulcer healing was observed in 98.1% of duodenal ulcers and 92.9% of gastric ulcers (based on per-protocol analysis). Mild side effects that did not require termination of treatment were reported by seven patients (6.7%).Conclusion: A 1-week course of famotidine, amoxicillin and clarithromycin is a highly effective, simple and safe eradication regimen. Our data indicate that acid suppression is the crucial mechanism by which the activity of amoxicillin and clarithromycin against H. pylori is enhanced, whereas additional antimicrobial activity or other specific effects of PPIs seem to be less important.
      pubtype: Academic Journal
      doctype:
        clinical trial
        research
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N